No announcement yet.

Going to Indy.

  • Filter
  • Time
  • Show
Clear All
new posts

  • Going to Indy.

    Hi everyone!

    The CT Scan and latest blood work came back normal. However, since the lab report indicated that there was a mixed germ cell, and it was embroynic carcinoma, that surgery is a strong possibility.

    My oncologist spoke directly with the doctors down in Indianapolis since in his estimation it is not a cut and dry case. I had stage 1B. He thinks it would do me good for them to view the slides, and all the reports directly.

    So, they are making an appointment to go down there. In the interim, they will do surveillence.


  • #2
    Sounds like an excellent plan. How soon is your appointment?
    Scott, [email protected]
    right inguinal orchiectomy 6/5/2003 > nonseminoma, stage I > surveillance > L-RPLND 6/24/2005 for recurrence, suspected teratoma but found seminoma, stage II > chylous ascites until 9/2005 > surveillance and "all clear" since

    Your donation funds Livestrong services for people facing cancer now. Please sponsor my ride!


    • #3
      They will be calling me in the next couple of days to let me know the date and time of the appointment.



      • #4
        Appointment is April 5 with Dr. Williams, who is in the same clinic as Dr. Einhorn at IU Cancer Center.

        ================================================== ========
        diagnosed: 2/2007 right orch. 2/26/07 lab3/1/07:mixed-germ cell 40% non-seminoma embroynic carcinoma 60% seminoma tc2 lymphatic invasion
        CT Scan 3/17/07: clear Blood test 3/15/07:normal. Consult at IU Cancer center 4/5/07
        ================================================== ======


        • #5
          Good luck and let us know what they find.
          Son Jason diagnosed 4/30/04, stage III. Right I/O 4/30/04. Graduated College 5/13/04. 4XEP 6/7/04 - 8/13/04. Full open RPLND 10/13/04. All Clear since.

          Treated by Dr. Rakowski of Midland Park, NJ. Visited Sloan Kettering for protocol advice. RPLND done at Sloan Kettering.